New York Proton Center

03/11/2026

Advancing the future of proton therapy through collaboration.

Last week, the New York Proton Center (NYPC) hosted its inaugural Consortium Research Retreat, bringing together radiation oncology experts from across our partner institutions.

Researchers and clinicians from NYPC, Memorial Sloan Kettering Cancer Center , Montefiore Health System, and The Mount Sinai Hospital gathered to share ideas and explore new collaborative research in proton therapy — from clinical trials and patient-reported outcomes to emerging areas like AI, FLASH radiotherapy, and adaptive treatment planning.

Special thanks to Dr. Isabelle Choi, Director of Research at NYPC, and Dr. Charles B. Simone II, Chief Medical Officer at NYPC, for their leadership, and to all the faculty who contributed to this inspiring day of discussion and collaboration.

03/11/2026

March 8-14 is Patient Safety Awareness Week.

At the New York Proton Center, patient safety is at the core of everything we do—from advanced quality assurance processes to continuous staff training and collaboration across our clinical teams.

Swipe through to learn more about the many safety practices that help ensure every treatment is delivered with precision and care.

03/09/2026

Celebrating Social Work Month 💛

This week, we recognized our incredible social work team at NYPC. This year’s theme — “Uplift. Defend. Transform.” — is reflected every day in the compassionate care provided by Chrissy Rubin, LCSW and Mark Eala, LMSW.

Thank you for the guidance, advocacy, and support you provide to our patients and families throughout their treatment journey.

Did our Social Work team make an impact during your care at NYPC? Share your experience in the comments. ⬇️

02/26/2026

February is American Heart Month — and it’s also a reminder that how we treat cancer today can impact heart health for years to come.

For many breast cancer patients, especially those with left-sided tumors, protecting the heart during radiation therapy is an important part of care. Proton therapy is designed to precisely target the tumor while reducing radiation exposure to the heart and lungs.

Read our blog to learn more:

At the NYPC, we are focused on advancing radiation therapy approaches that treat cancer effectively while minimizing short- and long-term risks for our patients. For patients with breast cancer, particularly left-sided disease, heart protection is a critical part of that conversation.

02/23/2026

Due to the blizzard affecting travel in the New York City region, we will open at 10 a.m. on Monday, February 23. NYPC staff will notify patients of their updated appointment time.

02/12/2026

Our people make the difference. 💙

From warm welcomes to thoughtful, attentive care, the NYPC team is committed to supporting patients throughout their treatment journey—every day, every visit.

02/04/2026

World Cancer Day serves as a powerful reminder of the importance of our work.

At NYPC, our mission is to provide advanced cancer care while offering unwavering support to patients and their families throughout their journey.

Today, and every day, we stand united with the global cancer community, supporting patients, care teams, research, survivors, and caregivers.

02/02/2026

How can radiation therapy be more precise—and help protect quality of life—for women with gynecologic cancers?

In our latest blog, Dr. Kristin Hsieh, Clinical Lead for Breast and Gynecologic Cancers at NYPC, shares how proton therapy is changing the way some gynecologic cancers are treated. By delivering radiation directly to the tumor while minimizing exposure to nearby organs, proton therapy may help reduce side effects and support long-term well-being.

Read more about when proton therapy may be an option for women with gynecologic cancers:

Radiation oncologist Kristin Hsieh, MD, explains the benefits of proton radiation therapy for treatment of gynecologic cancers.

01/27/2026

Lung cancer screening plays an important role in saving lives through early detection.

In a recent Oncology News Central article, Dr. Charles B. Simone II, Chief Medical Officer at the New York Proton Center, joined leaders from national medical societies in reinforcing the value of low-dose CT lung cancer screening when guided by high-quality evidence.

Dr. Simone explains that accurate interpretation of screening data is essential, as early detection allows more patients to be diagnosed at a stage when treatment may be most effective. Clear, evidence-based communication helps patients and clinicians make informed decisions about preventive care.



Read the full article here:

Three prominent medical societies are pushing back against what they describe as misleading claims about the risks of lung cancer screening, which they say could hinder screening uptake and lead to advanced and harder-to-treat disease.

01/26/2026

The team closed out 2025 with gratitude and generosity during our annual holiday toy drive. This season, staff, patients, and visitors came together to donate new toys of nominal value for NYPC’s pediatric patients—helping bring moments of joy to children and families during treatment.

Thanks to the support of our new nonprofit NYPC Foundation, we were proud to collect a record-breaking number of toy donations this year.

A special thank you to Drs. Ninfa and Keyur Mehta for their involvement in contributing an astounding number of gifts through Unity SME, a national 501(c)(3) organization dedicated to providing education on the importance of social responsibility.

01/13/2026

Treating cervical cancer is not just about stopping the disease; it is also about helping patients maintain their quality of life. Dr. Kristin Hsieh, Clinical Lead for Breast and Gynecologic Cancers at NYPC, shares why precision proton therapy may be the optimal treatment for cervical cancer.

By limiting radiation exposure to nearby healthy organs such as the bladder, bowel, and kidneys, proton therapy may help lower the risk of treatment-related side effects—both during and after care.

Learn about proton therapy for gynecologic cancers: nyproton.com/conditions/gynecologic-cancers/

01/05/2026

New research is changing what is possible for patients with head and neck cancers.

A large Phase III trial published in The Lancet shows that proton therapy can help patients live longer while protecting critical organs involved in speech, swallowing, and quality of life. At the New York Proton Center, we are proud to be part of research that advances care and puts patients first.

To learn more: nyproton.com/new-phase-iii-study-shows-proton-therapy-significantly-improves-survival-and-reduces-toxicity-in-head-and-neck-cancers